Walker et al. demonstrated that the JAK3, STAT1, STAT4, and STAT6 sublining expression was decreased in response to successful treatment of RA with standard disease-modifying antirheumatic drugs [15]. This evidence concerns the gene JAK3 and rheumatoid arthritis.